<svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" version="1.1" class="marks" width="574" height="447" viewBox="0 0 574 447"><rect width="574" height="447" fill="white"/><g fill="none" stroke-miterlimit="10" transform="translate(64,87)"><g class="mark-group role-frame root" role="graphics-object" aria-roledescription="group mark container"><g transform="translate(0,0)"><path class="background" aria-hidden="true" d="M0,0h500v300h-500Z" stroke="lightgray" stroke-width="0.5"/><g><g class="mark-group role-axis" aria-hidden="true"><g transform="translate(0.5,0.5)"><path class="background" aria-hidden="true" d="M0,0h0v0h0Z" pointer-events="none"/><g><g class="mark-rule role-axis-grid" pointer-events="none"><line transform="translate(0,300)" x2="500" y2="0" stroke="lightgray" stroke-opacity="0.4" stroke-width="1" opacity="1"/><line transform="translate(0,273)" x2="500" y2="0" stroke="lightgray" stroke-opacity="0.4" stroke-width="1" opacity="1"/><line transform="translate(0,245)" x2="500" y2="0" stroke="lightgray" stroke-opacity="0.4" stroke-width="1" opacity="1"/><line transform="translate(0,218)" x2="500" y2="0" stroke="lightgray" stroke-opacity="0.4" stroke-width="1" opacity="1"/><line transform="translate(0,191)" x2="500" y2="0" stroke="lightgray" stroke-opacity="0.4" stroke-width="1" opacity="1"/><line transform="translate(0,164)" x2="500" y2="0" stroke="lightgray" stroke-opacity="0.4" stroke-width="1" opacity="1"/><line transform="translate(0,136)" x2="500" y2="0" stroke="lightgray" stroke-opacity="0.4" stroke-width="1" opacity="1"/><line transform="translate(0,109)" x2="500" y2="0" stroke="lightgray" stroke-opacity="0.4" stroke-width="1" opacity="1"/><line transform="translate(0,82)" x2="500" y2="0" stroke="lightgray" stroke-opacity="0.4" stroke-width="1" opacity="1"/><line transform="translate(0,55)" x2="500" y2="0" stroke="lightgray" stroke-opacity="0.4" stroke-width="1" opacity="1"/><line transform="translate(0,27)" x2="500" y2="0" stroke="lightgray" stroke-opacity="0.4" stroke-width="1" opacity="1"/><line transform="translate(0,0)" x2="500" y2="0" stroke="lightgray" stroke-opacity="0.4" stroke-width="1" opacity="1"/></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g></g><g class="mark-group role-axis" role="graphics-symbol" aria-roledescription="axis" aria-label="X-axis for a discrete scale with 13 values: 0, 1, 2, 3, 4, ending with 12"><g transform="translate(0.5,300.5)"><path class="background" aria-hidden="true" d="M0,0h0v0h0Z" pointer-events="none"/><g><g class="mark-rule role-axis-tick" pointer-events="none"><line transform="translate(19,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(57,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(96,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(134,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(173,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(211,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(250,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(288,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(326,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(365,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(403,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(442,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(480,0)" x2="0" y2="5" stroke="#888" stroke-width="1" opacity="1"/></g><g class="mark-text role-axis-label" pointer-events="none"><text text-anchor="end" transform="translate(18.73076923076924,7) rotate(270) translate(0,3)" font-family="Arial" font-size="11px" fill="black" opacity="1">0</text><text text-anchor="end" transform="translate(57.1923076923077,7) rotate(270) translate(0,3)" font-family="Arial" font-size="11px" fill="black" opacity="1">1</text><text text-anchor="end" transform="translate(95.65384615384616,7) rotate(270) translate(0,3)" font-family="Arial" font-size="11px" fill="black" opacity="1">2</text><text text-anchor="end" transform="translate(134.11538461538464,7) rotate(270) translate(0,3)" font-family="Arial" font-size="11px" fill="black" opacity="1">3</text><text text-anchor="end" transform="translate(172.5769230769231,7) rotate(270) translate(0,3)" font-family="Arial" font-size="11px" fill="black" opacity="1">4</text><text text-anchor="end" transform="translate(211.03846153846155,7) rotate(270) translate(0,3)" font-family="Arial" font-size="11px" fill="black" opacity="1">5</text><text text-anchor="end" transform="translate(249.5,7) rotate(270) translate(0,3)" font-family="Arial" font-size="11px" fill="black" opacity="1">6</text><text text-anchor="end" transform="translate(287.9615384615385,7) rotate(270) translate(0,3)" font-family="Arial" font-size="11px" fill="black" opacity="1">7</text><text text-anchor="end" transform="translate(326.42307692307696,7) rotate(270) translate(0,3)" font-family="Arial" font-size="11px" fill="black" opacity="1">8</text><text text-anchor="end" transform="translate(364.8846153846154,7) rotate(270) translate(0,3)" font-family="Arial" font-size="11px" fill="black" opacity="1">9</text><text text-anchor="end" transform="translate(403.34615384615387,7) rotate(270) translate(0,3)" font-family="Arial" font-size="11px" fill="black" opacity="1">10</text><text text-anchor="end" transform="translate(441.8076923076923,7) rotate(270) translate(0,3)" font-family="Arial" font-size="11px" fill="black" opacity="1">11</text><text text-anchor="end" transform="translate(480.2692307692308,7) rotate(270) translate(0,3)" font-family="Arial" font-size="11px" fill="black" opacity="1">12</text></g><g class="mark-rule role-axis-domain" pointer-events="none"><line transform="translate(0,0)" x2="500" y2="0" stroke="black" stroke-width="0.5" opacity="1"/></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g></g><g class="mark-group role-axis" role="graphics-symbol" aria-roledescription="axis" aria-label="Y-axis titled 'Number of Participants' for a linear scale with values from 0 to 220"><g transform="translate(0.5,0.5)"><path class="background" aria-hidden="true" d="M0,0h0v0h0Z" pointer-events="none"/><g><g class="mark-rule role-axis-tick" pointer-events="none"><line transform="translate(0,300)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,273)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,245)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,218)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,191)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,164)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,136)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,109)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,82)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,55)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,27)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/><line transform="translate(0,0)" x2="-5" y2="0" stroke="#888" stroke-width="1" opacity="1"/></g><g class="mark-text role-axis-label" pointer-events="none"><text text-anchor="end" transform="translate(-7,303)" font-family="Arial" font-size="11px" fill="black" opacity="1">0</text><text text-anchor="end" transform="translate(-7,275.7272727272727)" font-family="Arial" font-size="11px" fill="black" opacity="1">20</text><text text-anchor="end" transform="translate(-7,248.45454545454544)" font-family="Arial" font-size="11px" fill="black" opacity="1">40</text><text text-anchor="end" transform="translate(-7,221.1818181818182)" font-family="Arial" font-size="11px" fill="black" opacity="1">60</text><text text-anchor="end" transform="translate(-7,193.9090909090909)" font-family="Arial" font-size="11px" fill="black" opacity="1">80</text><text text-anchor="end" transform="translate(-7,166.63636363636363)" font-family="Arial" font-size="11px" fill="black" opacity="1">100</text><text text-anchor="end" transform="translate(-7,139.36363636363637)" font-family="Arial" font-size="11px" fill="black" opacity="1">120</text><text text-anchor="end" transform="translate(-7,112.0909090909091)" font-family="Arial" font-size="11px" fill="black" opacity="1">140</text><text text-anchor="end" transform="translate(-7,84.81818181818181)" font-family="Arial" font-size="11px" fill="black" opacity="1">160</text><text text-anchor="end" transform="translate(-7,57.54545454545453)" font-family="Arial" font-size="11px" fill="black" opacity="1">180</text><text text-anchor="end" transform="translate(-7,30.27272727272728)" font-family="Arial" font-size="11px" fill="black" opacity="1">200</text><text text-anchor="end" transform="translate(-7,3)" font-family="Arial" font-size="11px" fill="black" opacity="1">220</text></g><g class="mark-rule role-axis-domain" pointer-events="none"><line transform="translate(0,300)" x2="0" y2="-300" stroke="black" stroke-width="0.5" opacity="1"/></g><g class="mark-text role-axis-title" pointer-events="none"><text text-anchor="middle" transform="translate(-40.35302734375,150) rotate(-90) translate(0,-3)" font-family="Arial" font-size="12px" font-weight="bold" fill="black" opacity="1">Number of Participants</text></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g></g><g class="mark-rect role-mark layer_0_marks" role="graphics-object" aria-roledescription="rect mark container"><path aria-label="Stage: 0; Number of Participants: 88; Diagnosis: CN; Count: 88; Percentage: 43.1%" role="graphics-symbol" aria-roledescription="bar" d="M1.923076923076934,180h34.61538461538461v120h-34.61538461538461Z" fill="#4477AA"/><path aria-label="Stage: 0; Number of Participants: 74; Diagnosis: EMCI; Count: 74; Percentage: 36.3%" role="graphics-symbol" aria-roledescription="bar" d="M1.923076923076934,79.0909090909091h34.61538461538461v100.9090909090909h-34.61538461538461Z" fill="#66CCEE"/><path aria-label="Stage: 0; Number of Participants: 42; Diagnosis: LMCI; Count: 42; Percentage: 20.6%" role="graphics-symbol" aria-roledescription="bar" d="M1.923076923076934,21.818181818181827h34.61538461538461v57.272727272727266h-34.61538461538461Z" fill="#228833"/><path aria-label="Stage: 0; Number of Participants: 0; Diagnosis: AD; Count: 0; Percentage: 0.0%" role="graphics-symbol" aria-roledescription="bar" d="M1.923076923076934,300h34.61538461538461v0h-34.61538461538461Z" fill="#EE6677"/><path aria-label="Stage: 1; Number of Participants: 0; Diagnosis: CN; Count: 0; Percentage: null" role="graphics-symbol" aria-roledescription="bar" d="M40.384615384615394,300h34.61538461538461v0h-34.61538461538461Z" fill="#4477AA"/><path aria-label="Stage: 1; Number of Participants: 0; Diagnosis: EMCI; Count: 0; Percentage: null" role="graphics-symbol" aria-roledescription="bar" d="M40.384615384615394,300h34.61538461538461v0h-34.61538461538461Z" fill="#66CCEE"/><path aria-label="Stage: 1; Number of Participants: 0; Diagnosis: LMCI; Count: 0; Percentage: null" role="graphics-symbol" aria-roledescription="bar" d="M40.384615384615394,300h34.61538461538461v0h-34.61538461538461Z" fill="#228833"/><path aria-label="Stage: 1; Number of Participants: 0; Diagnosis: AD; Count: 0; Percentage: null" role="graphics-symbol" aria-roledescription="bar" d="M40.384615384615394,300h34.61538461538461v0h-34.61538461538461Z" fill="#EE6677"/><path aria-label="Stage: 2; Number of Participants: 39; Diagnosis: CN; Count: 39; Percentage: 38.6%" role="graphics-symbol" aria-roledescription="bar" d="M78.84615384615385,246.8181818181818h34.61538461538461v53.18181818181819h-34.61538461538461Z" fill="#4477AA"/><path aria-label="Stage: 2; Number of Participants: 44; Diagnosis: EMCI; Count: 44; Percentage: 43.6%" role="graphics-symbol" aria-roledescription="bar" d="M78.84615384615385,186.81818181818184h34.61538461538461v59.99999999999997h-34.61538461538461Z" fill="#66CCEE"/><path aria-label="Stage: 2; Number of Participants: 18; Diagnosis: LMCI; Count: 18; Percentage: 17.8%" role="graphics-symbol" aria-roledescription="bar" d="M78.84615384615385,162.27272727272728h34.61538461538461v24.54545454545456h-34.61538461538461Z" fill="#228833"/><path aria-label="Stage: 2; Number of Participants: 0; Diagnosis: AD; Count: 0; Percentage: 0.0%" role="graphics-symbol" aria-roledescription="bar" d="M78.84615384615385,300h34.61538461538461v0h-34.61538461538461Z" fill="#EE6677"/><path aria-label="Stage: 3; Number of Participants: 4; Diagnosis: CN; Count: 4; Percentage: 44.4%" role="graphics-symbol" aria-roledescription="bar" d="M117.30769230769232,294.54545454545456h34.61538461538461v5.454545454545439h-34.61538461538461Z" fill="#4477AA"/><path aria-label="Stage: 3; Number of Participants: 3; Diagnosis: EMCI; Count: 3; Percentage: 33.3%" role="graphics-symbol" aria-roledescription="bar" d="M117.30769230769232,290.45454545454544h34.61538461538461v4.090909090909122h-34.61538461538461Z" fill="#66CCEE"/><path aria-label="Stage: 3; Number of Participants: 2; Diagnosis: LMCI; Count: 2; Percentage: 22.2%" role="graphics-symbol" aria-roledescription="bar" d="M117.30769230769232,287.72727272727275h34.61538461538461v2.727272727272691h-34.61538461538461Z" fill="#228833"/><path aria-label="Stage: 3; Number of Participants: 0; Diagnosis: AD; Count: 0; Percentage: 0.0%" role="graphics-symbol" aria-roledescription="bar" d="M117.30769230769232,300h34.61538461538461v0h-34.61538461538461Z" fill="#EE6677"/><path aria-label="Stage: 4; Number of Participants: 16; Diagnosis: CN; Count: 16; Percentage: 25.8%" role="graphics-symbol" aria-roledescription="bar" d="M155.76923076923077,278.1818181818182h34.61538461538461v21.818181818181813h-34.61538461538461Z" fill="#4477AA"/><path aria-label="Stage: 4; Number of Participants: 19; Diagnosis: EMCI; Count: 19; Percentage: 30.6%" role="graphics-symbol" aria-roledescription="bar" d="M155.76923076923077,252.27272727272728h34.61538461538461v25.909090909090907h-34.61538461538461Z" fill="#66CCEE"/><path aria-label="Stage: 4; Number of Participants: 27; Diagnosis: LMCI; Count: 27; Percentage: 43.5%" role="graphics-symbol" aria-roledescription="bar" d="M155.76923076923077,215.45454545454547h34.61538461538461v36.81818181818181h-34.61538461538461Z" fill="#228833"/><path aria-label="Stage: 4; Number of Participants: 0; Diagnosis: AD; Count: 0; Percentage: 0.0%" role="graphics-symbol" aria-roledescription="bar" d="M155.76923076923077,300h34.61538461538461v0h-34.61538461538461Z" fill="#EE6677"/><path aria-label="Stage: 5; Number of Participants: 2; Diagnosis: CN; Count: 2; Percentage: 8.0%" role="graphics-symbol" aria-roledescription="bar" d="M194.23076923076923,293.1818181818182h34.61538461538461v2.727272727272691h-34.61538461538461Z" fill="#4477AA"/><path aria-label="Stage: 5; Number of Participants: 7; Diagnosis: EMCI; Count: 7; Percentage: 28.0%" role="graphics-symbol" aria-roledescription="bar" d="M194.23076923076923,283.6363636363636h34.61538461538461v9.545454545454561h-34.61538461538461Z" fill="#66CCEE"/><path aria-label="Stage: 5; Number of Participants: 13; Diagnosis: LMCI; Count: 13; Percentage: 52.0%" role="graphics-symbol" aria-roledescription="bar" d="M194.23076923076923,265.9090909090909h34.61538461538461v17.727272727272748h-34.61538461538461Z" fill="#228833"/><path aria-label="Stage: 5; Number of Participants: 3; Diagnosis: AD; Count: 3; Percentage: 12.0%" role="graphics-symbol" aria-roledescription="bar" d="M194.23076923076923,295.9090909090909h34.61538461538461v4.090909090909122h-34.61538461538461Z" fill="#EE6677"/><path aria-label="Stage: 6; Number of Participants: 2; Diagnosis: CN; Count: 2; Percentage: 6.3%" role="graphics-symbol" aria-roledescription="bar" d="M232.6923076923077,293.1818181818182h34.61538461538461v2.727272727272691h-34.61538461538461Z" fill="#4477AA"/><path aria-label="Stage: 6; Number of Participants: 10; Diagnosis: EMCI; Count: 10; Percentage: 31.3%" role="graphics-symbol" aria-roledescription="bar" d="M232.6923076923077,279.54545454545456h34.61538461538461v13.636363636363626h-34.61538461538461Z" fill="#66CCEE"/><path aria-label="Stage: 6; Number of Participants: 17; Diagnosis: LMCI; Count: 17; Percentage: 53.1%" role="graphics-symbol" aria-roledescription="bar" d="M232.6923076923077,256.3636363636364h34.61538461538461v23.181818181818187h-34.61538461538461Z" fill="#228833"/><path aria-label="Stage: 6; Number of Participants: 3; Diagnosis: AD; Count: 3; Percentage: 9.4%" role="graphics-symbol" aria-roledescription="bar" d="M232.6923076923077,295.9090909090909h34.61538461538461v4.090909090909122h-34.61538461538461Z" fill="#EE6677"/><path aria-label="Stage: 7; Number of Participants: 0; Diagnosis: CN; Count: 0; Percentage: 0.0%" role="graphics-symbol" aria-roledescription="bar" d="M271.1538461538462,259.0909090909091h34.61538461538461v0h-34.61538461538461Z" fill="#4477AA"/><path aria-label="Stage: 7; Number of Participants: 7; Diagnosis: EMCI; Count: 7; Percentage: 9.5%" role="graphics-symbol" aria-roledescription="bar" d="M271.1538461538462,249.54545454545453h34.61538461538461v9.54545454545459h-34.61538461538461Z" fill="#66CCEE"/><path aria-label="Stage: 7; Number of Participants: 37; Diagnosis: LMCI; Count: 37; Percentage: 50.0%" role="graphics-symbol" aria-roledescription="bar" d="M271.1538461538462,199.09090909090907h34.61538461538461v50.45454545454547h-34.61538461538461Z" fill="#228833"/><path aria-label="Stage: 7; Number of Participants: 30; Diagnosis: AD; Count: 30; Percentage: 40.5%" role="graphics-symbol" aria-roledescription="bar" d="M271.1538461538462,259.0909090909091h34.61538461538461v40.90909090909088h-34.61538461538461Z" fill="#EE6677"/><path aria-label="Stage: 8; Number of Participants: 4; Diagnosis: CN; Count: 4; Percentage: 10.3%" role="graphics-symbol" aria-roledescription="bar" d="M309.61538461538464,278.1818181818182h34.61538461538461v5.454545454545439h-34.61538461538461Z" fill="#4477AA"/><path aria-label="Stage: 8; Number of Participants: 6; Diagnosis: EMCI; Count: 6; Percentage: 15.4%" role="graphics-symbol" aria-roledescription="bar" d="M309.61538461538464,270h34.61538461538461v8.181818181818187h-34.61538461538461Z" fill="#66CCEE"/><path aria-label="Stage: 8; Number of Participants: 17; Diagnosis: LMCI; Count: 17; Percentage: 43.6%" role="graphics-symbol" aria-roledescription="bar" d="M309.61538461538464,246.8181818181818h34.61538461538461v23.181818181818187h-34.61538461538461Z" fill="#228833"/><path aria-label="Stage: 8; Number of Participants: 12; Diagnosis: AD; Count: 12; Percentage: 30.8%" role="graphics-symbol" aria-roledescription="bar" d="M309.61538461538464,283.6363636363636h34.61538461538461v16.363636363636374h-34.61538461538461Z" fill="#EE6677"/><path aria-label="Stage: 9; Number of Participants: 0; Diagnosis: CN; Count: 0; Percentage: 0.0%" role="graphics-symbol" aria-roledescription="bar" d="M348.0769230769231,286.3636363636364h34.61538461538461v0h-34.61538461538461Z" fill="#4477AA"/><path aria-label="Stage: 9; Number of Participants: 3; Diagnosis: EMCI; Count: 3; Percentage: 12.0%" role="graphics-symbol" aria-roledescription="bar" d="M348.0769230769231,282.27272727272725h34.61538461538461v4.090909090909122h-34.61538461538461Z" fill="#66CCEE"/><path aria-label="Stage: 9; Number of Participants: 12; Diagnosis: LMCI; Count: 12; Percentage: 48.0%" role="graphics-symbol" aria-roledescription="bar" d="M348.0769230769231,265.9090909090909h34.61538461538461v16.363636363636374h-34.61538461538461Z" fill="#228833"/><path aria-label="Stage: 9; Number of Participants: 10; Diagnosis: AD; Count: 10; Percentage: 40.0%" role="graphics-symbol" aria-roledescription="bar" d="M348.0769230769231,286.3636363636364h34.61538461538461v13.636363636363626h-34.61538461538461Z" fill="#EE6677"/><path aria-label="Stage: 10; Number of Participants: 0; Diagnosis: CN; Count: 0; Percentage: 0.0%" role="graphics-symbol" aria-roledescription="bar" d="M386.53846153846155,250.90909090909093h34.61538461538461v0h-34.61538461538461Z" fill="#4477AA"/><path aria-label="Stage: 10; Number of Participants: 6; Diagnosis: EMCI; Count: 6; Percentage: 9.2%" role="graphics-symbol" aria-roledescription="bar" d="M386.53846153846155,242.72727272727272h34.61538461538461v8.181818181818215h-34.61538461538461Z" fill="#66CCEE"/><path aria-label="Stage: 10; Number of Participants: 23; Diagnosis: LMCI; Count: 23; Percentage: 35.4%" role="graphics-symbol" aria-roledescription="bar" d="M386.53846153846155,211.36363636363637h34.61538461538461v31.363636363636346h-34.61538461538461Z" fill="#228833"/><path aria-label="Stage: 10; Number of Participants: 36; Diagnosis: AD; Count: 36; Percentage: 55.4%" role="graphics-symbol" aria-roledescription="bar" d="M386.53846153846155,250.90909090909093h34.61538461538461v49.090909090909065h-34.61538461538461Z" fill="#EE6677"/><path aria-label="Stage: 11; Number of Participants: 0; Diagnosis: CN; Count: 0; Percentage: 0.0%" role="graphics-symbol" aria-roledescription="bar" d="M425,259.0909090909091h34.61538461538461v0h-34.61538461538461Z" fill="#4477AA"/><path aria-label="Stage: 11; Number of Participants: 3; Diagnosis: EMCI; Count: 3; Percentage: 6.3%" role="graphics-symbol" aria-roledescription="bar" d="M425,255h34.61538461538461v4.090909090909122h-34.61538461538461Z" fill="#66CCEE"/><path aria-label="Stage: 11; Number of Participants: 15; Diagnosis: LMCI; Count: 15; Percentage: 31.3%" role="graphics-symbol" aria-roledescription="bar" d="M425,234.54545454545456h34.61538461538461v20.45454545454544h-34.61538461538461Z" fill="#228833"/><path aria-label="Stage: 11; Number of Participants: 30; Diagnosis: AD; Count: 30; Percentage: 62.5%" role="graphics-symbol" aria-roledescription="bar" d="M425,259.0909090909091h34.61538461538461v40.90909090909088h-34.61538461538461Z" fill="#EE6677"/><path aria-label="Stage: 12; Number of Participants: 0; Diagnosis: CN; Count: 0; Percentage: 0.0%" role="graphics-symbol" aria-roledescription="bar" d="M463.46153846153845,260.45454545454544h34.61538461538461v0h-34.61538461538461Z" fill="#4477AA"/><path aria-label="Stage: 12; Number of Participants: 0; Diagnosis: EMCI; Count: 0; Percentage: 0.0%" role="graphics-symbol" aria-roledescription="bar" d="M463.46153846153845,260.45454545454544h34.61538461538461v0h-34.61538461538461Z" fill="#66CCEE"/><path aria-label="Stage: 12; Number of Participants: 13; Diagnosis: LMCI; Count: 13; Percentage: 31.0%" role="graphics-symbol" aria-roledescription="bar" d="M463.46153846153845,242.72727272727272h34.61538461538461v17.72727272727272h-34.61538461538461Z" fill="#228833"/><path aria-label="Stage: 12; Number of Participants: 29; Diagnosis: AD; Count: 29; Percentage: 69.0%" role="graphics-symbol" aria-roledescription="bar" d="M463.46153846153845,260.45454545454544h34.61538461538461v39.54545454545456h-34.61538461538461Z" fill="#EE6677"/></g><g class="mark-text role-mark layer_1_marks" role="graphics-object" aria-roledescription="text mark container"><text aria-label="Stage: 0; Total: 204; Total Sample Size: 204" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(19.23076923076924,13)" font-family="sans-serif" font-size="9px" fill="black">204</text><text aria-label="Stage: 0; Total: 204; Total Sample Size: 204" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(19.23076923076924,13)" font-family="sans-serif" font-size="9px" fill="black">204</text><text aria-label="Stage: 0; Total: 204; Total Sample Size: 204" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(19.23076923076924,13)" font-family="sans-serif" font-size="9px" fill="black">204</text><text aria-label="Stage: 0; Total: 204; Total Sample Size: 204" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(19.23076923076924,13)" font-family="sans-serif" font-size="9px" fill="black">204</text><text aria-label="Stage: 1; Total: 0; Total Sample Size: 0" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(57.6923076923077,13)" font-family="sans-serif" font-size="9px" fill="black">0</text><text aria-label="Stage: 1; Total: 0; Total Sample Size: 0" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(57.6923076923077,13)" font-family="sans-serif" font-size="9px" fill="black">0</text><text aria-label="Stage: 1; Total: 0; Total Sample Size: 0" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(57.6923076923077,13)" font-family="sans-serif" font-size="9px" fill="black">0</text><text aria-label="Stage: 1; Total: 0; Total Sample Size: 0" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(57.6923076923077,13)" font-family="sans-serif" font-size="9px" fill="black">0</text><text aria-label="Stage: 2; Total: 101; Total Sample Size: 101" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(96.15384615384616,13)" font-family="sans-serif" font-size="9px" fill="black">101</text><text aria-label="Stage: 2; Total: 101; Total Sample Size: 101" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(96.15384615384616,13)" font-family="sans-serif" font-size="9px" fill="black">101</text><text aria-label="Stage: 2; Total: 101; Total Sample Size: 101" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(96.15384615384616,13)" font-family="sans-serif" font-size="9px" fill="black">101</text><text aria-label="Stage: 2; Total: 101; Total Sample Size: 101" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(96.15384615384616,13)" font-family="sans-serif" font-size="9px" fill="black">101</text><text aria-label="Stage: 3; Total: 9; Total Sample Size: 9" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(134.61538461538464,13)" font-family="sans-serif" font-size="9px" fill="black">9</text><text aria-label="Stage: 3; Total: 9; Total Sample Size: 9" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(134.61538461538464,13)" font-family="sans-serif" font-size="9px" fill="black">9</text><text aria-label="Stage: 3; Total: 9; Total Sample Size: 9" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(134.61538461538464,13)" font-family="sans-serif" font-size="9px" fill="black">9</text><text aria-label="Stage: 3; Total: 9; Total Sample Size: 9" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(134.61538461538464,13)" font-family="sans-serif" font-size="9px" fill="black">9</text><text aria-label="Stage: 4; Total: 62; Total Sample Size: 62" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(173.0769230769231,13)" font-family="sans-serif" font-size="9px" fill="black">62</text><text aria-label="Stage: 4; Total: 62; Total Sample Size: 62" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(173.0769230769231,13)" font-family="sans-serif" font-size="9px" fill="black">62</text><text aria-label="Stage: 4; Total: 62; Total Sample Size: 62" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(173.0769230769231,13)" font-family="sans-serif" font-size="9px" fill="black">62</text><text aria-label="Stage: 4; Total: 62; Total Sample Size: 62" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(173.0769230769231,13)" font-family="sans-serif" font-size="9px" fill="black">62</text><text aria-label="Stage: 5; Total: 25; Total Sample Size: 25" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(211.53846153846155,13)" font-family="sans-serif" font-size="9px" fill="black">25</text><text aria-label="Stage: 5; Total: 25; Total Sample Size: 25" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(211.53846153846155,13)" font-family="sans-serif" font-size="9px" fill="black">25</text><text aria-label="Stage: 5; Total: 25; Total Sample Size: 25" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(211.53846153846155,13)" font-family="sans-serif" font-size="9px" fill="black">25</text><text aria-label="Stage: 5; Total: 25; Total Sample Size: 25" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(211.53846153846155,13)" font-family="sans-serif" font-size="9px" fill="black">25</text><text aria-label="Stage: 6; Total: 32; Total Sample Size: 32" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(250,13)" font-family="sans-serif" font-size="9px" fill="black">32</text><text aria-label="Stage: 6; Total: 32; Total Sample Size: 32" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(250,13)" font-family="sans-serif" font-size="9px" fill="black">32</text><text aria-label="Stage: 6; Total: 32; Total Sample Size: 32" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(250,13)" font-family="sans-serif" font-size="9px" fill="black">32</text><text aria-label="Stage: 6; Total: 32; Total Sample Size: 32" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(250,13)" font-family="sans-serif" font-size="9px" fill="black">32</text><text aria-label="Stage: 7; Total: 74; Total Sample Size: 74" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(288.4615384615385,13)" font-family="sans-serif" font-size="9px" fill="black">74</text><text aria-label="Stage: 7; Total: 74; Total Sample Size: 74" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(288.4615384615385,13)" font-family="sans-serif" font-size="9px" fill="black">74</text><text aria-label="Stage: 7; Total: 74; Total Sample Size: 74" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(288.4615384615385,13)" font-family="sans-serif" font-size="9px" fill="black">74</text><text aria-label="Stage: 7; Total: 74; Total Sample Size: 74" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(288.4615384615385,13)" font-family="sans-serif" font-size="9px" fill="black">74</text><text aria-label="Stage: 8; Total: 39; Total Sample Size: 39" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(326.92307692307696,13)" font-family="sans-serif" font-size="9px" fill="black">39</text><text aria-label="Stage: 8; Total: 39; Total Sample Size: 39" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(326.92307692307696,13)" font-family="sans-serif" font-size="9px" fill="black">39</text><text aria-label="Stage: 8; Total: 39; Total Sample Size: 39" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(326.92307692307696,13)" font-family="sans-serif" font-size="9px" fill="black">39</text><text aria-label="Stage: 8; Total: 39; Total Sample Size: 39" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(326.92307692307696,13)" font-family="sans-serif" font-size="9px" fill="black">39</text><text aria-label="Stage: 9; Total: 25; Total Sample Size: 25" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(365.3846153846154,13)" font-family="sans-serif" font-size="9px" fill="black">25</text><text aria-label="Stage: 9; Total: 25; Total Sample Size: 25" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(365.3846153846154,13)" font-family="sans-serif" font-size="9px" fill="black">25</text><text aria-label="Stage: 9; Total: 25; Total Sample Size: 25" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(365.3846153846154,13)" font-family="sans-serif" font-size="9px" fill="black">25</text><text aria-label="Stage: 9; Total: 25; Total Sample Size: 25" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(365.3846153846154,13)" font-family="sans-serif" font-size="9px" fill="black">25</text><text aria-label="Stage: 10; Total: 65; Total Sample Size: 65" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(403.84615384615387,13)" font-family="sans-serif" font-size="9px" fill="black">65</text><text aria-label="Stage: 10; Total: 65; Total Sample Size: 65" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(403.84615384615387,13)" font-family="sans-serif" font-size="9px" fill="black">65</text><text aria-label="Stage: 10; Total: 65; Total Sample Size: 65" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(403.84615384615387,13)" font-family="sans-serif" font-size="9px" fill="black">65</text><text aria-label="Stage: 10; Total: 65; Total Sample Size: 65" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(403.84615384615387,13)" font-family="sans-serif" font-size="9px" fill="black">65</text><text aria-label="Stage: 11; Total: 48; Total Sample Size: 48" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(442.3076923076923,13)" font-family="sans-serif" font-size="9px" fill="black">48</text><text aria-label="Stage: 11; Total: 48; Total Sample Size: 48" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(442.3076923076923,13)" font-family="sans-serif" font-size="9px" fill="black">48</text><text aria-label="Stage: 11; Total: 48; Total Sample Size: 48" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(442.3076923076923,13)" font-family="sans-serif" font-size="9px" fill="black">48</text><text aria-label="Stage: 11; Total: 48; Total Sample Size: 48" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(442.3076923076923,13)" font-family="sans-serif" font-size="9px" fill="black">48</text><text aria-label="Stage: 12; Total: 42; Total Sample Size: 42" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(480.7692307692308,13)" font-family="sans-serif" font-size="9px" fill="black">42</text><text aria-label="Stage: 12; Total: 42; Total Sample Size: 42" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(480.7692307692308,13)" font-family="sans-serif" font-size="9px" fill="black">42</text><text aria-label="Stage: 12; Total: 42; Total Sample Size: 42" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(480.7692307692308,13)" font-family="sans-serif" font-size="9px" fill="black">42</text><text aria-label="Stage: 12; Total: 42; Total Sample Size: 42" role="graphics-symbol" aria-roledescription="text mark" text-anchor="middle" transform="translate(480.7692307692308,13)" font-family="sans-serif" font-size="9px" fill="black">42</text></g><g class="mark-group role-legend" role="graphics-symbol" aria-roledescription="legend" aria-label="Symbol legend for fill color with 4 values: CN, EMCI, LMCI, AD"><g transform="translate(0,-29)"><path class="background" aria-hidden="true" d="M0,0h181v11h-181Z" pointer-events="none"/><g><g class="mark-group role-legend-entry"><g transform="translate(0,0)"><path class="background" aria-hidden="true" d="M0,0h0v0h0Z" pointer-events="none"/><g><g class="mark-group role-scope" role="graphics-object" aria-roledescription="group mark container"><g transform="translate(0,0)"><path class="background" aria-hidden="true" d="M0,0h31.8876953125v11h-31.8876953125Z" pointer-events="none" opacity="1"/><g><g class="mark-symbol role-legend-symbol" pointer-events="none"><path transform="translate(6,6)" d="M-5,-5h10v10h-10Z" fill="#4477AA" stroke-width="1.5" opacity="1"/></g><g class="mark-text role-legend-label" pointer-events="none"><text text-anchor="start" transform="translate(16,9)" font-family="sans-serif" font-size="11px" fill="#000" opacity="1">CN</text></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g><g transform="translate(42,0)"><path class="background" aria-hidden="true" d="M0,0h43.5v11h-43.5Z" pointer-events="none" opacity="1"/><g><g class="mark-symbol role-legend-symbol" pointer-events="none"><path transform="translate(6,6)" d="M-5,-5h10v10h-10Z" fill="#66CCEE" stroke-width="1.5" opacity="1"/></g><g class="mark-text role-legend-label" pointer-events="none"><text text-anchor="start" transform="translate(16,9)" font-family="sans-serif" font-size="11px" fill="#000" opacity="1">EMCI</text></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g><g transform="translate(96,0)"><path class="background" aria-hidden="true" d="M0,0h42.28076171875v11h-42.28076171875Z" pointer-events="none" opacity="1"/><g><g class="mark-symbol role-legend-symbol" pointer-events="none"><path transform="translate(6,6)" d="M-5,-5h10v10h-10Z" fill="#228833" stroke-width="1.5" opacity="1"/></g><g class="mark-text role-legend-label" pointer-events="none"><text text-anchor="start" transform="translate(16,9)" font-family="sans-serif" font-size="11px" fill="#000" opacity="1">LMCI</text></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g><g transform="translate(149,0)"><path class="background" aria-hidden="true" d="M0,0h31.28076171875v11h-31.28076171875Z" pointer-events="none" opacity="1"/><g><g class="mark-symbol role-legend-symbol" pointer-events="none"><path transform="translate(6,6)" d="M-5,-5h10v10h-10Z" fill="#EE6677" stroke-width="1.5" opacity="1"/></g><g class="mark-text role-legend-label" pointer-events="none"><text text-anchor="start" transform="translate(16,9)" font-family="sans-serif" font-size="11px" fill="#000" opacity="1">AD</text></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g></g><g class="mark-group role-title"><g transform="translate(250,-47)"><path class="background" aria-hidden="true" d="M0,0h0v0h0Z" pointer-events="none"/><g><g class="mark-text role-title-text" role="graphics-symbol" aria-roledescription="title" aria-label="Title text 'Distribution of Disease Stages by Diagnosis, DEBM GMM'" pointer-events="none"><text text-anchor="middle" transform="translate(0,1)" font-family="sans-serif" font-size="14px" font-weight="normal" fill="#000" opacity="1">Distribution of Disease Stages by Diagnosis, DEBM GMM</text></g></g><path class="foreground" aria-hidden="true" d="" pointer-events="none" display="none"/></g></g></g><path class="foreground" aria-hidden="true" d="" display="none"/></g></g></g></svg>